PIK3CA and head and neck squamous cell carcinoma: Accordingly, co‐inhibition of these RTKs using a multi‐kinase inhibitor ponatinib eliminates CSCs and reduces metastasis of PIK3CA‐overexpressing head and neck squamous cell carcinoma cells.